#news #biotech Flagship’s Evelo files for $100M IPO as human testing of monoclonal microbials nears

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Flagship’s Evelo files for $100M IPO as human testing of monoclonal microbials nears .Evelo Biosciences has filed for a $100 million initial public offering. The pitch to public investors comes as the Flagship Ventures’ startup prepares to test its lead inflammatory disease and anticancer microbial strains in humans.

from FierceBiotech: Biotech https://ift.tt/2EPB0ny